Skip to main content
logo
Skybiotech Healthcare Limited (BOM:512036)
India flag India · Delayed Price · Currency is INR
167.00
-0.50 (-0.30%)
At close: Aug 4, 2026

Skybiotech Healthcare Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
74.0474.0474.3620.020.540.23
Revenue Growth
-0.43%-0.43%271.34%3597.53%138.36%16.26%
Gross Profit
34.9434.9436.6220.020.540.23
Operating Income
-16.46-16.46-24.1218.75-0.07-0.38
Net Income
-11.17-11.17-23.6915.35-0.07-0.38
Earnings Per Share
-6.70-6.70-12.378.02-0.07-0.36
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Short-Term Investments
-5.94-5.94-2.6984.330.170.12
Total Debt
84.1584.1571.98---
Net Cash (Debt)
-90.1-90.1-74.6784.330.170.12
Net Cash Growth
---48132.08%49.45%-33.85%
Net Cash Per Share
-54.05-54.05-38.9944.040.170.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-15.16-15.16-10.43-13.37-3.736.1
Capital Expenditures
-0.02-0.02-3.26---
Free Cash Flow
-15.18-15.18-13.68-13.37-3.736.1
Free Cash Flow Growth
------52.37%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
47.19%47.19%49.25%100.00%100.00%100.00%
Operating Margin
-22.23%-22.23%-32.44%93.64%-13.62%-166.50%
Pretax Margin
-22.51%-22.51%-32.62%93.64%-13.62%-166.50%
Profit Margin
-15.08%-15.08%-31.86%76.68%-13.37%-166.58%
FCF Margin
-20.50%-20.50%-18.40%-66.76%-688.68%2683.86%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
---16.24--
P/FCF Ratio
-----4.26
PS Ratio
4.323.984.2112.4565.55114.44